Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients & plaques at a significantly higher risk for subsequent MACE. View now View Now
We would love to hear from you! Please send a message or give us a call.
© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative
